CA25525-2 - 0x0000000000003AB7

Males & Females of Non-Childbearing Potential

Rose

* Stipend may pay up to reflected amount.
Start Date: 
February 25, 2019 - 3:00pm
End Date: 
March 5, 2019 - 7:30am

Study Details

Study Number: CA25525
Group Number: 2
Study Requirement: Healthy Normal Female
Stipend: up to $2,000.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat a genetic disorder in which bone gradually replaces muscle tissue.
Route of Administration: Oral
Blood Draws: 19

Study Schedule

Schedule Type: Short stays with returns
Study Length: One - 5 Night Stay & 1 Return

Screening Dates:

Event Day Event Date
Tuesday 2/19/2019

Doctor Exam Dates:

Event Day Event Date
Tuesday 2/19/2019

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Monday 2/25/2019 3:00:00 PM Saturday 3/2/2019 7:30:00 AM 1 Lincoln
Return Tuesday 3/5/2019 6:30:00 AM Tuesday 3/5/2019 7:30:00 AM 1 Lincoln